B2B pricing strategy for Series A companies: the 90-day install for PE-backed portfolio companies
The exact 90-day plan for standing up B2B pricing strategy at Series A — the point where the founder can no longer be every function. Written for operating partners and portfolio CEOs inside private equity.
This edition is written for operating partners and portfolio CEOs inside private equity. In PE-backed portfolio companies, PE-backed operators run on 90-day cycles and reward operating rigor over storytelling, so the way you install B2B pricing strategy has to reflect that reality from day one.
Series A is the moment B2B pricing strategy stops being optional. The founder has to step out of some of the work, the plan requires a defensible growth number, and every quarter compounds toward the next raise.
Day 1 to 30: diagnosis and instrumentation. Name the constraint, write the ICP, wire net revenue retention into the board pack.
Day 31 to 60: first live cycle at 20% of planned volume. Founder still in every review. Kill criteria written and enforced.
The binding constraint we see in PE-backed portfolio companies is almost always predictable execution against a hold-period thesis. B2B pricing strategy is only useful in this vertical when it is pointed at that constraint — not at a generic growth number borrowed from another category.
Day 61 to 90: ramp to full volume, hire the first dedicated operator, and hand off ops. Founder retains strategy and the weekly review.
By day 90 the metric is legible and the trajectory is defensible. This is what turns a Series A story into a Series B round.
Trap most Series A companies fall into: matching a competitor instead of pricing to value. It usually shows up around day 45 when the founder tries to hire ahead of the model.
The Series A version of B2B pricing strategy looks small compared to what you will build at Series B. That is the point — it is a foundation, not a monument.
Concretely for PE-backed portfolio companies: the portfolio companies that install this hit the next value-creation milestone on schedule. That is the reason it is worth installing B2B pricing strategy properly rather than half-heartedly across three vendors.
Frequently asked questions
Pricing · PE-backed — answered
- Does B2B pricing strategy work for PE-backed portfolio companies?
- Yes — provided it is aimed at predictable execution against a hold-period thesis rather than a generic growth number. The portfolio companies that install this hit the next value-creation milestone on schedule.
- Should we start B2B pricing strategy before Series A?
- Yes if the founder has time; the Series A version is the same model at higher spend.
- How much of the round should fund B2B pricing strategy?
- Meaningful — often 20–30% of the growth line — but only after diagnosis.
- When do we hire the first B2B pricing strategy operator?
- Around day 60, once the model has run one full cycle with the founder.
- What Series A trap should we avoid?
- Matching a competitor instead of pricing to value — usually a premature senior hire.
- What is the PE-backed specific pitfall with B2B pricing strategy?
- Running the generic playbook without adapting to PE-backed operators run on 90-day cycles and reward operating rigor over storytelling. The install has to be vertical-first.
Growth Broker editorial
Filed under pricing · pe-backed